https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg00IOZKhttps://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svgIOZK2015-08-12 16:59:282019-02-12 17:01:22Neue Antikörper für die immunologische Krebstherapie zugelassen
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg00IOZKhttps://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svgIOZK2015-07-03 17:04:122019-02-12 17:04:44ZEIT-Beilage: Leben mit Krebs mit einem Beitrag über das IOZK und der IOZK Immuntherapie
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg00IOZKhttps://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svgIOZK2015-06-15 17:07:482020-05-27 11:39:56IOZK Fallstudie zum Langzeitüberleben einer Patientin mit Brustkrebs
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg00IOZKhttps://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svgIOZK2015-06-12 17:06:232019-02-12 17:07:27Beitrag von Prof. Dr. Schirrmacher in der Wiener medizinischen Wochenschrift „Skriptum“
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg00IOZKhttps://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svgIOZK2015-04-12 17:11:582019-02-12 17:12:51IOZK erhält Herstellungserlaubnis für den patienteneigenen Tumorimpfstoff
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg00IOZKhttps://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svgIOZK2014-09-12 17:20:592019-02-12 19:53:44Verleihung des UNESCO-L’Oréal-Preises „Women in Science“
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg00IOZKhttps://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svgIOZK2014-09-10 17:18:392019-02-12 17:19:00Artikel im Deutschen Ärzteblatt zum Thema: Tumorbiologie
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg00IOZKhttps://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svgIOZK2013-04-12 17:22:322019-02-12 17:22:47Science kürt Immuntherapie gegen Krebs 2013 zum „Breakthrough of the Year“
New antibodies approved for immunological cancer therapy
ZEIT supplement: Living with cancer, featuring an article about the IOZK and IOZK immunotherapy
IOZK case study on the long-term survival of a patient with breast cancer
Article by Prof. Dr. Schirrmacher in the Vienna medical weekly "Skriptum"
IOZK receives manufacturing license for patient-specific tumor vaccine
Prof. Dr. Schirrmacher publishes e-book: Harnessing Oncolytic Virus-mediated Antitumor Immunity
Presentation of the UNESCO-L'Oréal Prize "Women in Science"
Article in Deutsches Ärzteblatt on the topic: Tumor biology
Science names immunotherapy against cancer "Breakthrough of the Year" for 2013